Premium Pharma OÜ
CopyRegistry data
Legal status
Company ID
14928540VAT code
EE102242083Registered
04/03/2020Share capital
2,500.00 €Contacts
Company registration address
Website
-
C
AverageReliability
C - Average
-3 ** during past year
Number of employees
29Credit limit
20-30 k €Credit report
Company's financial performance and creditability assessment.
+21.56 % ** during past year
Taxes
243.2KDebts
-+12.20 % ** during past year
Taxable turnover
1.9M
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 5,443,713 |
| 181,457 |
| 39,972 |
| 39,972 |
| 1,332 |
| -0.01 |
| 10.73 |
| 1.39 |
| 75,669 |
| 1.39 |
| 75,669 |
| 25.95 |
| 0.73 |
| 106,938 |
| 1,147,629 |
| 155,000 |
| 1,099,567 |
| 2023 |
|---|
| 5,979,527 |
| 186,860 |
| -97,786 |
| -97,786 |
| -3,056 |
| -0.02 |
| 128.48 |
| -3.34 |
| -199,666 |
| -3.34 |
| -199,666 |
| 25.17 |
| -1.64 |
| 9,152 |
| 1,175,819 |
| 155,000 |
| 1,029,971 |
| 2024 |
|---|
| 6,599,547 |
| 212,889 |
| -4,874 |
| -4,874 |
| -157 |
| -0.02 |
| 300.75 |
| -0.26 |
| -16,874 |
| -0.26 |
| -16,874 |
| 23.21 |
| -0.07 |
| 4,277 |
| 1,286,287 |
| 155,000 |
| 1,135,564 |
| 2024 |
|---|
| 6,599,547 |
| 212,889 |
| -4,874 |
| -4,874 |
| -157 |
| -0.02 |
| 300.75 |
| -0.26 |
| -16,874 |
| -0.26 |
| -16,874 |
| 23.21 |
| -0.07 |
| 4,277 |
| 1,286,287 |
| 155,000 |
| 1,135,564 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
14928533Reg. date:
04/03/2020Turnover:
-No. of employees:
21Category:
Retail sale of pharmaceutical productsComp. code:
14922306Reg. date:
27/02/2020Turnover:
-No. of employees:
23Category:
Retail sale of pharmaceutical productsComp. code:
14922803Reg. date:
27/02/2020Turnover:
-No. of employees:
25Category:
Retail sale of pharmaceutical productsComp. code:
14923106Reg. date:
27/02/2020Turnover:
-No. of employees:
22Category:
Retail sale of pharmaceutical productsComp. code:
14921715Reg. date:
26/02/2020Turnover:
-No. of employees:
21